Media
Posts from the Concordare team, press coverage, and moments from the road.
MediaJune 4, 2026Local tech startups pitch to be next big thing
via Axios Pittsburgh
Concordare takes the stage at AlphaLab Demo Day, pitching its patented fully digital protocol platform to investors alongside 20 other cohort companies.
Read on Axios Pittsburgh
Company NewsJune 3, 2026Techstars Demo Day
via LinkedIn
Our founder Zach presented at Techstars AI Health Baltimore Demo Day as part of the '26 cohort.
Read on LinkedIn
Company NewsJune 3, 2026AlphaLab Demo Day
via LinkedIn
We took the stage at AlphaLab Demo Day as part of the '26 AL Health cohort.
Read on LinkedIn
Company NewsMay 20, 2026Clinical Trials Day 2026
via LinkedIn
We attended Clinical Trials Day 2026 at Rutgers Health as a part of our partnership with them.
Read on LinkedIn
Product UpdateMay 6, 2026Introducing the Clinical Trial Protocol Model (CTPM)
Concordare Team · 5 min read
A structured, machine-readable protocol that powers every downstream deliverable from a single extraction.
Read more
Company NewsApril 24, 2026ACRP Annual Conference 2026
via LinkedIn
Some members of our team attended the ACRP 2026 Conference, sharing what we're building with the clinical research community.
Read on LinkedIn- Industry InsightsApril 22, 2026
What unified infrastructure changes
Concordare Team · 7 min read
Most clinical software is built around a single study. Coordinators run dozens at once. Here's what changes when you flip the design axis.
Read more 
Company NewsMarch 9, 2026Meet the startups joining Techstars' Spring 2026 accelerator programs
via Techstars
Concordare Trials chosen for the Techstars AI Health program, joining a global cohort of health and AI companies across 43 Techstars verticals.
Read on Techstars- Company NewsFebruary 26, 2026
Concordare closes pre-seed round
Concordare Team · 2 min read
We're growing the team and expanding use of the platform across the clinical research ecosystem.
Read more 
MediaFebruary 23, 2026Standardizing clinical trial setup with Concordare Trials
via NYU Stern Berkeley Center for Entrepreneurship
An in-depth interview with founder Zach Sawaged on the origin of Concordare, the inefficiency built into how clinical trials are run today, and what a protocol-first approach actually changes.
Read on NYU Stern Berkeley Center for Entrepreneurship
MediaFebruary 10, 2026AlphaLab selects 20 startups for 2026 cohort embedding intelligence into industry
via Business Wire
Concordare Trials announced as part of AlphaLab Health's 2026 cohort, a program run in collaboration with Allegheny Health Network and Innovation Works.
Read on Business Wire
MediaFebruary 10, 2026AlphaLab launches its biggest cohort yet
via Technical.ly
Concordare spotlighted as one of the standout health companies in the AlphaLab 2026 class, one of the most competitive cohorts the program has run in its history.
Read on Technical.ly